contact ussite map
Juvaris plans to start up four (4) clinical studies in 2008.
Juvaris Pipeline
Juvaris is Conducting Clinical Trials.
Juvaris Technology
Juvaris BioTherapeutics' Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial
Juvaris BioTherapeutics Announces Progress in Alliance with Bayer Animal Health
Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine
Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvanted Seasonal Influenza Vaccine
More »
   
Terms of Use  |  Legal  |  Site Users Guide
© 2009 Juvaris BioTherapeutics.